Dayton Clinical Oncology Program | Dayton, OH

Research site

Location

6480 Centerville Business Parkway, Dayton, Ohio, United States of America

Website

https://daytonncorp.org/index.html

Site insights

Top conditions

Top treatments

Bevacizumab

Paclitaxel

Carboplatin

Dexamethasone

Trastuzumab

Lenalidomide

Cyclophosphamide

Doxorubicin Hydrochloride

Cisplatin

Pertuzumab

Parent organization

This site is a part of Dayton Clinical Oncology Program

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Contact this site

Amy Dempe

Verified by this site

Active trials

1 of 90 total trials

Study of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling (FB-12)

This is a prospective, single arm, open label, multicenter interventional study designed to evaluate the efficacy of neoadjuvant chemotherapy with an...

Enrolling

HER2-negative Breast Cancer

Drug: Doxorubicin

Drug: Cyclophosphamide

Trial sponsors

U

G

C

G

Clinical trials

Find clinical trials Trials by location

Research sites

Find research sites Learn about CTV for professionals

Resources

Contact CTV support

Legal

Privacy Notice Terms